BAFFA, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 2.725
AS - Asia 961
EU - Europa 586
AF - Africa 263
SA - Sud America 208
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 12
Totale 4.788
Nazione #
US - Stati Uniti d'America 2.581
SG - Singapore 376
HK - Hong Kong 140
CN - Cina 134
BR - Brasile 125
VN - Vietnam 67
DE - Germania 63
FI - Finlandia 60
SE - Svezia 53
IT - Italia 40
UA - Ucraina 35
GB - Regno Unito 29
RU - Federazione Russa 28
FR - Francia 25
MK - Macedonia 17
JP - Giappone 16
NL - Olanda 16
AR - Argentina 15
AT - Austria 15
IN - India 15
MX - Messico 15
PL - Polonia 15
PS - Palestinian Territory 15
TT - Trinidad e Tobago 14
PE - Perù 13
AL - Albania 12
KR - Corea 12
PR - Porto Rico 12
IQ - Iraq 11
LU - Lussemburgo 11
MZ - Mozambico 11
RS - Serbia 11
ZA - Sudafrica 11
AZ - Azerbaigian 10
BZ - Belize 10
CI - Costa d'Avorio 10
CO - Colombia 10
ES - Italia 10
PA - Panama 10
TR - Turchia 10
BA - Bosnia-Erzegovina 9
BJ - Benin 9
CY - Cipro 9
ET - Etiopia 9
GA - Gabon 9
HU - Ungheria 9
MR - Mauritania 9
NG - Nigeria 9
NI - Nicaragua 9
SA - Arabia Saudita 9
SK - Slovacchia (Repubblica Slovacca) 9
AO - Angola 8
AU - Australia 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
GF - Guiana Francese 8
HR - Croazia 8
IS - Islanda 8
KH - Cambogia 8
MA - Marocco 8
ME - Montenegro 8
SD - Sudan 8
XK - ???statistics.table.value.countryCode.XK??? 8
YT - Mayotte 8
AF - Afghanistan, Repubblica islamica di 7
BB - Barbados 7
BE - Belgio 7
BF - Burkina Faso 7
BO - Bolivia 7
CA - Canada 7
CL - Cile 7
CU - Cuba 7
CV - Capo Verde 7
EG - Egitto 7
GN - Guinea 7
GP - Guadalupe 7
GR - Grecia 7
GT - Guatemala 7
ID - Indonesia 7
IE - Irlanda 7
IR - Iran 7
KZ - Kazakistan 7
MG - Madagascar 7
ML - Mali 7
MY - Malesia 7
NZ - Nuova Zelanda 7
PH - Filippine 7
PY - Paraguay 7
TW - Taiwan 7
TZ - Tanzania 7
UG - Uganda 7
BD - Bangladesh 6
BG - Bulgaria 6
BW - Botswana 6
CG - Congo 6
CM - Camerun 6
CR - Costa Rica 6
DJ - Gibuti 6
EC - Ecuador 6
EE - Estonia 6
Totale 4.529
Città #
Fairfield 360
Woodbridge 239
Ann Arbor 218
Singapore 210
Chandler 179
Houston 177
Ashburn 167
Santa Clara 151
Cambridge 143
Wilmington 141
Hong Kong 138
Jacksonville 120
Seattle 118
Princeton 69
Boardman 48
Beijing 35
San Diego 35
Los Angeles 32
Nanjing 23
Buffalo 18
Ho Chi Minh City 18
Helsinki 17
Medford 17
São Paulo 16
Guangzhou 14
Dong Ket 12
Munich 12
Des Moines 11
Hanoi 11
Nuremberg 11
Padova 11
Skopje 11
Bytom 10
Redondo Beach 10
Abidjan 9
Baku 9
Libreville 9
Managua 9
Maputo 9
Nouakchott 9
Panama City 9
San Juan 9
Tokyo 9
Vienna 9
Addis Ababa 8
Cotonou 8
Luanda 8
Nanchang 8
Phnom Penh 8
Podgorica 8
Antananarivo 7
Bamako 7
Conakry 7
Havana 7
Johannesburg 7
Lima 7
London 7
New York 7
Praia 7
Salt Lake City 7
Amman 6
Atlanta 6
Belgrade 6
Belize City 6
Bridgetown 6
Cayenne 6
Dar es Salaam 6
Kampala 6
Kingstown 6
Lagos 6
Papeete 6
Ramallah 6
Riga 6
Santo Domingo 6
Yaoundé 6
Belo Horizonte 5
Brooklyn 5
Dakar 5
Djibouti 5
Dublin 5
Dushanbe 5
Gaborone 5
Harare 5
Jiaxing 5
Les Abymes 5
Lusaka 5
Mamoudzou 5
Nairobi 5
Nassau 5
Nicosia 5
Norwalk 5
Ouagadougou 5
Pristina 5
Reykjavik 5
San Jose 5
San José 5
Tirana 5
Vientiane 5
Accra 4
Amsterdam 4
Totale 3.223
Nome #
Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. 238
MicroRNA expression profiling in human Barrett's carcinogenesis. 187
Advanced precancerous lesions within the GI tract: the molecular background. 166
MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options. 157
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. 156
GASTRIC EPITHELIAL DYSPLASIA - A PROSPECTIVE MULTICENTER FOLLOW-UP-STUDY FROM THE INTERDISCIPLINARY-GROUP-ON-GASTRIC- EPITHELIAL-DYSPLASIA 153
Helicobacter pylori in promotion of gastric carcinogenesis 152
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets 150
Micrornas As Tools And Effectors For Patient Treatment In Gastrointestinal Carcinogenesis. 149
An antimetastatic role for decorin in breast cancer 144
MicroRNAs and targeted therapy: small molecules of unlimited potentials. 143
GASTRIC EPITHELIAL DYSPLASIA 143
BIOCHEMICAL AND HISTOPATHOLOGICAL ASPECTS IN DUODENOGASTRIC REFLUX GASTRITIS PATIENTS WITH OR WITHOUT PRIOR CHOLECYSTECTOMY 140
Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach 138
Leucine zipper putative tumor suppressor 1 - [Isoform 1] 136
Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain. 135
Are tryptase and cathepsin D related to Helicobacter pylori infection and mucosal gastrin in peptic ulcer? 134
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. 134
Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. 130
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread. 130
Micro-RNA profiling in kidney and bladder cancers. 129
Proepithelin is an autocrine growth factor for bladder cancer. 128
Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. 124
MircoRNA expression profiling of male breast cancer. 122
Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. 121
SUCRALFATE, RANITIDINE AND NO TREATMENT IN GASTRIC-ULCER MANAGEMENT - A MULTICENTER, PROSPECTIVE, RANDOMIZED, 24-MONTH FOLLOW-UP WITH A STUDY OF RISK-FACTORS OF RELAPSE 119
Effect of proepithelin on prostate cancer cell biology: Cell growth, migration and anchorage-independent growth. 118
EARLY AND ADVANCED GASTRIC-CANCER IN THE FOLLOW-UP OF MODERATE AND SEVERE GASTRIC DYSPLASIA PATIENTS - A PROSPECTIVE-STUDY 116
IMMUNOHISTOCHEMICAL EVIDENCE OF P53 OVEREXPRESSION IN GASTRIC EPITHELIAL DYSPLASIA 115
Fez1/Lzts1 alterations in gastric carcinoma 114
ESOPHAGITIS AND PH OF THE REFLUXATE - EXPERIMENTAL AND CLINICAL-STUDY 110
LONG-TERM TREATMENT OF PATIENTS WITH GASTRIC-ULCER - SUCRALFATE VERSUS RANITIDINE VERSUS NO TREATMENT - AN INTERIM-REPORT AT THE END OF YEAR-1 OF A 3-YEAR MULTICENTER, RANDOMIZED STUDY 102
Molecular genetics of prostate cancer: clinical translational opportunities. 100
Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines 92
Loss of FHIT expression in gastric carcinoma 92
Targeted therapies in the management of metastatic bladder cancer. 76
Totale 4.793
Categoria #
all - tutte 14.652
article - articoli 13.950
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 412
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 28 5 25 55 16 33 26
2021/2022481 34 43 74 34 17 26 12 64 11 15 55 96
2022/2023350 83 50 2 36 65 28 4 23 34 2 15 8
2023/2024139 5 19 26 12 5 3 5 12 13 3 17 19
2024/2025701 1 29 17 6 186 27 38 46 51 24 119 157
2025/20261.602 94 226 444 507 275 56 0 0 0 0 0 0
Totale 4.793